Gateway Investment Advisers LLC Abiomed Inc Transaction History

Gateway Investment Advisers LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 15, 2019	SELL	$175.89 - $279.23 $293,736 - $466,314	-1,670 Closed	0 $0
Q2 2019 Jul 17, 2019	SELL	$250.96 - $284.94 $19,072 - $21,655	-76 Reduced 4.35%	1,670 $435,000
Q1 2019 Apr 10, 2019	SELL	$276.39 - $362.25 $22,940 - $30,066	-83 Reduced 4.54%	1,746 $499,000
Q4 2018 Jan 14, 2019	BUY	$281.08 - $444.25 $27,826 - $43,980	99 Added 5.72%	1,829 $594,000
Q3 2018 Oct 16, 2018	SELL	$354.53 - $449.75 $36,871 - $46,774	-104 Reduced 5.67%	1,730 $778,000
Q2 2018 Jul 11, 2018	BUY	$278.07 - $446.21 $509,980 - $818,349	1,834 New	1,834 $750,000

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Gateway Investment Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Gateway Investment Advisers LLC with notifications on news.